IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
Interest Income Expense
IDT Australia Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDT Australia Ltd
ASX:IDT
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Interest Income Expense
-AU$19.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Interest Income Expense
AU$208k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Interest Income Expense
AU$17.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Interest Income Expense
-AU$6m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-15%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Interest Income Expense
AU$1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|